DS
ARRY

DRW Securities’s Array Biopharma Inc ARRY Stock Holding History

DRW Securities’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,200
Closed -$287K – 189
2019
Q2 		$287K Buy
+6,200
New +$174K 0.02% 91

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

DRW Securities's ARRY Position: Q2 2018 in Review

DRW Securities sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 10,000 shares — an estimated $163K sold.

DRW Securities first reported a position in ARRY in Q3 2017 and held it in 3 quarters. The position peaked at $246K in Q3 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • DRW Securities reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • DRW Securities sold 10,000 Array Biopharma Inc shares in Q2 2018, an estimated $163K.
  • DRW Securities first reported a position in Array Biopharma Inc in Q3 2017 and held it in 3 quarters.
  • DRW Securities's Array Biopharma Inc position peaked at $246K in Q3 2017.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on DRW Securities's 13F filing for Q2 2018, filed 14 Aug 2018.